VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy.
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy. Cancer Res. 2011 Aug 15; 71(16):5445-54.
View in:
PubMed
subject areas
Animals
Antigens, CD
CTLA-4 Antigen
Enzyme-Linked Immunosorbent Assay
Inducible T-Cell Co-Stimulator Ligand
Lymphocytes, Tumor-Infiltrating
Melanoma, Experimental
Mice
Mice, Inbred C57BL
Proteins
authors with profiles
PADMANEE SHARMA